ImmuCell reports preliminary Q2 sales increase of 11.5% to $7.2M
Seeking Alpha ·
ImmuCell ( ICCC ) on Thursday announced preliminary, unaudited sales results for the second quarter of 2026. Total sales for the three months ended June 30, 2026, were $7.2M, an 11.5% increase compared to the three months ended June 30, 2025, driven by a 27.7% increase in domestic sales compared
DYAX Investor Sentiment
Bullish (Long) 42% · Bearish (Short) 58%
349 participants
Related News
- Bausch + Lomb abandons glaucoma drops after phase 2 failure
- Gold bounces above $4,100 as traders buy the dip
- Hongli Group receives Nasdaq deficiency notice after shares fall below $1 rule
- Stock movers after hours: BIRK, EL, AMZN
- The Caldwell Partners International Inc. GAAP EPS of C$0.054, revenue of C$28.82M
- Goldman Sachs bars staff from prediction market trades on finance and war - report